Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122712252 | 12271225 | 2 | F | 20160309 | 20160704 | 20160415 | 20160711 | EXP | FR-TEVA-652309ACC | TEVA | 64.79 | YR | F | Y | 0.00000 | 20160711 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122712252 | 12271225 | 1 | PS | Levact | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous drip | 187 MILLIGRAM DAILY; | 374 | MG | U | 22249 | 187 | MG | POWDER FOR INJECTION | QD | |||
| 122712252 | 12271225 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | (ONCE DAILY) (6TH CYCLE) | U | 74284 | 310 | MG | |||||||
| 122712252 | 12271225 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 312 MILLIGRAM DAILY; | 624 | MG | U | 0 | 312 | MG | QD | ||||
| 122712252 | 12271225 | 4 | SS | ZOPHREN /00955301/ | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 16 MILLIGRAM DAILY; | 64 | MG | U | 0 | 8 | MG | BID | ||||
| 122712252 | 12271225 | 5 | SS | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MILLIGRAM DAILY; | Y | 0 | 40 | MG | QD | ||||||
| 122712252 | 12271225 | 6 | SS | EMEND | APREPITANT | 1 | Oral | 80 MILLIGRAM DAILY; | 320 | MG | U | 0 | 80 | MG | QD | ||||
| 122712252 | 12271225 | 7 | C | SECTRAL | ACEBUTOLOL HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 122712252 | 12271225 | 8 | C | FLECAINE | FLECAINIDE | 1 | Unknown | 0 | |||||||||||
| 122712252 | 12271225 | 9 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 122712252 | 12271225 | 10 | C | CHIBRO CADRON | DEXAMETHASONE SODIUM PHOSPHATENEOMYCIN SULFATE | 1 | Unknown | 0 | |||||||||||
| 122712252 | 12271225 | 11 | C | ELUDRIL /00676401/ | 2 | Unknown | 0 | ||||||||||||
| 122712252 | 12271225 | 12 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | Unknown | 0 | MOUTH WASH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122712252 | 12271225 | 1 | T-cell lymphoma |
| 122712252 | 12271225 | 2 | T-cell lymphoma |
| 122712252 | 12271225 | 3 | T-cell lymphoma |
| 122712252 | 12271225 | 4 | Product used for unknown indication |
| 122712252 | 12271225 | 5 | Product used for unknown indication |
| 122712252 | 12271225 | 6 | Product used for unknown indication |
| 122712252 | 12271225 | 7 | Tachycardia |
| 122712252 | 12271225 | 8 | Tachycardia |
| 122712252 | 12271225 | 9 | Product used for unknown indication |
| 122712252 | 12271225 | 10 | Product used for unknown indication |
| 122712252 | 12271225 | 11 | Product used for unknown indication |
| 122712252 | 12271225 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122712252 | 12271225 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122712252 | 12271225 | Acute kidney injury | |
| 122712252 | 12271225 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122712252 | 12271225 | 1 | 20160309 | 20160310 | 0 | |
| 122712252 | 12271225 | 2 | 20160311 | 20160311 | 0 | |
| 122712252 | 12271225 | 3 | 20160311 | 20160312 | 0 | |
| 122712252 | 12271225 | 4 | 20160309 | 20160313 | 0 | |
| 122712252 | 12271225 | 5 | 20160308 | 0 | ||
| 122712252 | 12271225 | 6 | 20160309 | 20160312 | 0 |